James Hattersley
Corporate Officer/Principal at PALATIN TECHNOLOGIES, INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| John Prendergast | M | 70 | 38 years | |
| Stephen Wills | M | 67 | 27 years | |
| Carl Spana | M | 61 | 38 years | |
| Robert deVeer | M | 78 | 26 years | |
| Mary Tagliaferri | M | 58 | 9 years | |
| Joseph Hull | M | 71 | 19 years | |
| Alan Dunton | M | 70 | 13 years | |
| Arlene Morris | F | 72 | 9 years | |
| Anthony Manning | M | 62 | 7 years | |
| Sanj Singh | M | - |
Temple Therapeutics BV
 Temple Therapeutics BV BiotechnologyHealth Technology Temple Therapeutics BV is a Dutch company that focuses on developing treatments and early detection diagnostics for tissue fibrosis, endometriosis, and ovarian cancer. Temple Therapeutics is based in Geleen, NL. The private company uses scientific innovations and a novel cellular metabolism approach to create a pipeline of highly differentiated diagnostic and drug candidates. The company prioritizes women's healthcare and aims to provide life-changing innovations. The company was founded in 2015, and the CEO is Sanj Singh. | - |
| Guy Jean L. Savoir | M | - |
Temple Therapeutics BV
Temple Therapeutics BV BiotechnologyHealth Technology Temple Therapeutics BV is a Dutch company that focuses on developing treatments and early detection diagnostics for tissue fibrosis, endometriosis, and ovarian cancer. Temple Therapeutics is based in Geleen, NL. The private company uses scientific innovations and a novel cellular metabolism approach to create a pipeline of highly differentiated diagnostic and drug candidates. The company prioritizes women's healthcare and aims to provide life-changing innovations. The company was founded in 2015, and the CEO is Sanj Singh. | - |
| Samrat Sisodia | M | - | - | |
| J. Wang | M | - | 3 years | |
| Michael Raizman | M | - | 3 years | |
| Jennifer Fox | F | - |
Temple Therapeutics BV
Temple Therapeutics BV BiotechnologyHealth Technology Temple Therapeutics BV is a Dutch company that focuses on developing treatments and early detection diagnostics for tissue fibrosis, endometriosis, and ovarian cancer. Temple Therapeutics is based in Geleen, NL. The private company uses scientific innovations and a novel cellular metabolism approach to create a pipeline of highly differentiated diagnostic and drug candidates. The company prioritizes women's healthcare and aims to provide life-changing innovations. The company was founded in 2015, and the CEO is Sanj Singh. | 5 years |
| Kelly Emerton | M | - |
Temple Therapeutics BV
Temple Therapeutics BV BiotechnologyHealth Technology Temple Therapeutics BV is a Dutch company that focuses on developing treatments and early detection diagnostics for tissue fibrosis, endometriosis, and ovarian cancer. Temple Therapeutics is based in Geleen, NL. The private company uses scientific innovations and a novel cellular metabolism approach to create a pipeline of highly differentiated diagnostic and drug candidates. The company prioritizes women's healthcare and aims to provide life-changing innovations. The company was founded in 2015, and the CEO is Sanj Singh. | - |
| Bill Densel | M | 56 |
Temple Therapeutics BV
Temple Therapeutics BV BiotechnologyHealth Technology Temple Therapeutics BV is a Dutch company that focuses on developing treatments and early detection diagnostics for tissue fibrosis, endometriosis, and ovarian cancer. Temple Therapeutics is based in Geleen, NL. The private company uses scientific innovations and a novel cellular metabolism approach to create a pipeline of highly differentiated diagnostic and drug candidates. The company prioritizes women's healthcare and aims to provide life-changing innovations. The company was founded in 2015, and the CEO is Sanj Singh. | - |
| Jonathan Zalevsky | M | 49 | 9 years | |
| Stephen Slusher | M | - | - | |
| Saad Urrehman Gilani | M | 53 |
Temple Therapeutics BV
Temple Therapeutics BV BiotechnologyHealth Technology Temple Therapeutics BV is a Dutch company that focuses on developing treatments and early detection diagnostics for tissue fibrosis, endometriosis, and ovarian cancer. Temple Therapeutics is based in Geleen, NL. The private company uses scientific innovations and a novel cellular metabolism approach to create a pipeline of highly differentiated diagnostic and drug candidates. The company prioritizes women's healthcare and aims to provide life-changing innovations. The company was founded in 2015, and the CEO is Sanj Singh. | 9 years |
| Steven P. Damon | M | 67 |
Temple Therapeutics BV
Temple Therapeutics BV BiotechnologyHealth Technology Temple Therapeutics BV is a Dutch company that focuses on developing treatments and early detection diagnostics for tissue fibrosis, endometriosis, and ovarian cancer. Temple Therapeutics is based in Geleen, NL. The private company uses scientific innovations and a novel cellular metabolism approach to create a pipeline of highly differentiated diagnostic and drug candidates. The company prioritizes women's healthcare and aims to provide life-changing innovations. The company was founded in 2015, and the CEO is Sanj Singh. | - |
| Zahir Lavji | M | 70 |
Temple Therapeutics BV
Temple Therapeutics BV BiotechnologyHealth Technology Temple Therapeutics BV is a Dutch company that focuses on developing treatments and early detection diagnostics for tissue fibrosis, endometriosis, and ovarian cancer. Temple Therapeutics is based in Geleen, NL. The private company uses scientific innovations and a novel cellular metabolism approach to create a pipeline of highly differentiated diagnostic and drug candidates. The company prioritizes women's healthcare and aims to provide life-changing innovations. The company was founded in 2015, and the CEO is Sanj Singh. | - |
| Brandi Roberts | F | 50 |
Temple Therapeutics BV
Temple Therapeutics BV BiotechnologyHealth Technology Temple Therapeutics BV is a Dutch company that focuses on developing treatments and early detection diagnostics for tissue fibrosis, endometriosis, and ovarian cancer. Temple Therapeutics is based in Geleen, NL. The private company uses scientific innovations and a novel cellular metabolism approach to create a pipeline of highly differentiated diagnostic and drug candidates. The company prioritizes women's healthcare and aims to provide life-changing innovations. The company was founded in 2015, and the CEO is Sanj Singh. | 5 years |
| John Dodd | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ivan Philip Gergel | M | 64 | 3 years | |
| Jitendra Doshi | M | 74 |
Sun Pharmaceutical Industries, Inc.
 Sun Pharmaceutical Industries, Inc. Pharmaceuticals: MajorHealth Technology Sun Pharmaceutical Industries, Inc. provides pharmaceutical products. Its products include petrochemical, drugs, vaccines and fertilizers. The company is headquartered in Cranbury, NJ. | 3 years |
| Robert A. Medv | M | 58 | 3 years | |
| Joseph Lasaga | M | - | 4 years | |
| Kanya Rajangam | M | 50 | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 20 | 68.97% |
| Netherlands | 9 | 31.03% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- James Hattersley
- Personal Network
